{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,24]],"date-time":"2026-01-24T05:52:06Z","timestamp":1769233926283,"version":"3.49.0"},"reference-count":38,"publisher":"e-Century Publishing Corporation","issue":"10","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Am J Transl Res"],"DOI":"10.62347\/edns9849","type":"journal-article","created":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T08:57:12Z","timestamp":1761728232000},"page":"7858-7867","source":"Crossref","is-referenced-by-count":1,"title":["Valproate sodium-associated acute pancreatitis: a case report and systematic analysis of antiepileptic drug adverse events in FAERS"],"prefix":"10.62347","volume":"17","author":[{"given":"Lujing","family":"Wang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"48694","published-online":{"date-parts":[[2025]]},"reference":[{"key":"ref0","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1016\/B978-0-444-64074-1.00045-8","article-title":"Thermoregulation in epilepsy","volume":"157","author":"Pollandt","year":"2018","unstructured":"Pollandt S and Bleck TP. Thermoregulation in epilepsy. Handb Clin Neurol 2018; 157: 737-747.","journal-title":"Handb Clin Neurol"},{"key":"ref1","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1111\/j.1528-1157.1978.tb04501.x","article-title":"Effect of valproate sodium on generalized penicillin epilepsy in the cat","volume":"19","author":"Pellegrini","year":"1978","unstructured":"Pellegrini A, Gloor P and Sherwin AL. Effect of valproate sodium on generalized penicillin epilepsy in the cat. Epilepsia 1978; 19: 351-360.","journal-title":"Epilepsia"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1001\/archneur.1979.00500410079012","article-title":"Comparative trial of valproate sodium and clonazepam in chronic epilepsy","volume":"36","author":"Shakir","year":"1979","unstructured":"Shakir RA, Nanda RN, Lambie DG and Johnson RH. Comparative trial of valproate sodium and clonazepam in chronic epilepsy. Arch Neurol 1979; 36: 301-304.","journal-title":"Arch Neurol"},{"key":"ref3","doi-asserted-by":"publisher","unstructured":"Gogri PY, Bhalerao S and Vuyyuru S. Sodium valproate-induced cataract. BMJ Case Rep 2021; 14: e240997.","DOI":"10.1136\/bcr-2020-240997"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"739","DOI":"10.2165\/00023210-200822090-00003","article-title":"CNS adverse events associated with antiepileptic drugs","volume":"22","author":"Kennedy","year":"2008","unstructured":"Kennedy GM and Lhatoo SD. CNS adverse events associated with antiepileptic drugs. CNS Drugs 2008; 22: 739-760.","journal-title":"CNS Drugs"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.seizure.2024.06.008","article-title":"Association of UGT1a6 gene polymorphisms with sodium valproate-induced tremor in patients with epilepsy","volume":"120","author":"Yin","year":"2024","unstructured":"Yin Z and Li P. Association of UGT1a6 gene polymorphisms with sodium valproate-induced tremor in patients with epilepsy. Seizure 2024; 120: 56-60.","journal-title":"Seizure"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/S0140-6736(81)90143-4","article-title":"Valproic acid associated pancreatitis in an adult","volume":"1","author":"Murphy","year":"1981","unstructured":"Murphy MJ, Lyon IW, Taylor JW and Mitts G. Valproic acid associated pancreatitis in an adult. Lancet 1981; 1: 41-42.","journal-title":"Lancet"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1159\/000510703","article-title":"Post-marketing safety concerns with esketamine: a disproportionality analysis of spontaneous reports submitted to the FDA adverse event reporting system","volume":"90","author":"Gastaldon","year":"2021","unstructured":"Gastaldon C, Raschi E, Kane JM, Barbui C and Schoretsanitis G. Post-marketing safety concerns with esketamine: a disproportionality analysis of spontaneous reports submitted to the FDA adverse event reporting system. Psychother Psychosom 2021; 90: 41-48.","journal-title":"Psychother Psychosom"},{"key":"ref8","doi-asserted-by":"publisher","unstructured":"Xiong CY, Yang YM, Zhou Y, He TS, Luo XW, Wang J and Mao CX. Systematic analysis of the adverse effects of commonly used clinical tetracycline drugs based on the FAERS database. Expert Opin Drug Saf 2025: 24: 949-957.","DOI":"10.1080\/14740338.2024.2392865"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"591","DOI":"10.2165\/00002018-200427080-00010","article-title":"Using MedDRA: implications for risk management","volume":"27","author":"Brown","year":"2004","unstructured":"Brown EG. Using MedDRA: implications for risk management. Drug Saf 2004; 27: 591-602.","journal-title":"Drug Saf"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"826","DOI":"10.3390\/cancers12040826","article-title":"Cardiovascular toxicity of tyrosine kinase inhibitors used in chronic myeloid leukemia: an analysis of the FDA adverse event reporting system database (FAERS)","volume":"12","author":"Cirmi","year":"2020","unstructured":"Cirmi S, El Abd A, Letinier L, Navarra M and Salvo F. Cardiovascular toxicity of tyrosine kinase inhibitors used in chronic myeloid leukemia: an analysis of the FDA adverse event reporting system database (FAERS). Cancers (Basel) 2020; 12: 826.","journal-title":"Cancers (Basel)"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1007\/s002280050466","article-title":"A bayesian neural network method for adverse drug reaction signal generation","volume":"54","author":"Bate","year":"1998","unstructured":"Bate A, Lindquist M, Edwards IR, Olsson S, Orre R, Lansner A and De Freitas RM. A bayesian neural network method for adverse drug reaction signal generation. Eur J Clin Pharmacol 1998; 54: 315-321.","journal-title":"Eur J Clin Pharmacol"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1136\/amiajnl-2012-001119","article-title":"Comparative analysis of pharmacovigilance methods in the detection of adverse drug reactions using electronic medical records","volume":"20","author":"Liu","year":"2013","unstructured":"Liu M, McPeek Hinz ER, Matheny ME, Denny JC, Schildcrout JS, Miller RA and Xu H. Comparative analysis of pharmacovigilance methods in the detection of adverse drug reactions using electronic medical records. J Am Med Inform Assoc 2013; 20: 420-426.","journal-title":"J Am Med Inform Assoc"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1007\/s002689900205","article-title":"Diagnostic standards for acute pancreatitis","volume":"21","author":"Ranson","year":"1997","unstructured":"Ranson JH. Diagnostic standards for acute pancreatitis. World J Surg 1997; 21: 136-142.","journal-title":"World J Surg"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1007\/s002689900206","article-title":"Acute pancreatitis: nonsurgical management","volume":"21","author":"Tenner","year":"1997","unstructured":"Tenner S and Banks PA. Acute pancreatitis: nonsurgical management. World J Surg 1997; 21: 143-148.","journal-title":"World J Surg"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"2747","DOI":"10.3748\/wjg.v29.i18.2747","article-title":"Current trends in acute pancreatitis: diagnostic and therapeutic challenges","volume":"29","author":"Zerem","year":"2023","unstructured":"Zerem E, Kurtcehajic A, Kunosic S, Zerem Malkočević D and Zerem O. Current trends in acute pancreatitis: diagnostic and therapeutic challenges. World J Gastroenterol 2023; 29: 2747-2763.","journal-title":"World J Gastroenterol"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/j.bpg.2010.02.002","article-title":"Drug induced pancreatitis","volume":"24","author":"Nitsche","year":"2010","unstructured":"Nitsche CJ, Jamieson N, Lerch MM and Mayerle JV. Drug induced pancreatitis. Best Pract Res Clin Gastroenterol 2010; 24: 143-155.","journal-title":"Best Pract Res Clin Gastroenterol"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"823","DOI":"10.2165\/00002018-200831100-00002","article-title":"Drug-induced pancreatitis: incidence, management and prevention","volume":"31","author":"Balani","year":"2008","unstructured":"Balani AR and Grendell JH. Drug-induced pancreatitis: incidence, management and prevention. Drug Saf 2008; 31: 823-837.","journal-title":"Drug Saf"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1097\/00006982-200110000-00025","article-title":"Purtscher retinopathy following drug-induced pancreatitis in an HIV-positive patient","volume":"21","author":"SK","year":"2001","unstructured":"Bui SK, O’Brien JM and Cunningham EJ. Purtscher retinopathy following drug-induced pancreatitis in an HIV-positive patient. Retina 2001; 21: 542-545.","journal-title":"Retina"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"2902","DOI":"10.3748\/wjg.v26.i22.2902","article-title":"Ever-increasing diversity of drug-induced pancreatitis","volume":"26","author":"Weissman","year":"2020","unstructured":"Weissman S, Aziz M, Perumpail RB, Mehta TI, Patel R and Tabibian JH. Ever-increasing diversity of drug-induced pancreatitis. World J Gastroenterol 2020; 26: 2902-2915.","journal-title":"World J Gastroenterol"},{"key":"ref20","unstructured":"Alberti-Flor JJ, Hernandez ME, Ferrer JP, Howell S and Jeffers L. Fulminant liver failure and pancreatitis associated with the use of sulfamethoxazole-trimethoprim. Am J Gastroenterol 1989; 84: 1577-1579."},{"key":"ref21","doi-asserted-by":"publisher","first-page":"1223","DOI":"10.1111\/j.1528-1167.2007.01041.x","article-title":"Idiosyncratic adverse reactions to antiepileptic drugs","volume":"48","author":"Zaccara","year":"2007","unstructured":"Zaccara G, Franciotta D and Perucca E. Idiosyncratic adverse reactions to antiepileptic drugs. Epilepsia 2007; 48: 1223-1244.","journal-title":"Epilepsia"},{"key":"ref22","unstructured":"Yang J, Ying Y, Jin L, Ying F, Fang J, Chen X, Zhu M and Yang X. Sertraline-induced acute pancreatitis: a case report and literature review. Altern Ther Health Med 2024; 30: 318-321."},{"key":"ref23","unstructured":"Klein SM and Khan MA. Hepatitis, toxic epidermal necrolysis and pancreatitis in association with sulindac therapy. J Rheumatol 1983; 10: 512-513."},{"key":"ref24","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1097\/01.mcg.0000173929.60115.b4","article-title":"Drug-induced pancreatitis: an update","volume":"39","author":"Trivedi","year":"2005","unstructured":"Trivedi CD and Pitchumoni CS. Drug-induced pancreatitis: an update. J Clin Gastroenterol 2005; 39: 709-716.","journal-title":"J Clin Gastroenterol"},{"key":"ref25","doi-asserted-by":"publisher","unstructured":"Wolfe D, Kanji S, Yazdi F, Skidmore B, Moher D and Hutton B. Methods for the early detection of drug-induced pancreatitis: a systematic review of the literature. BMJ Open 2019; 9: e027451.","DOI":"10.1136\/bmjopen-2018-027451"},{"key":"ref26","doi-asserted-by":"publisher","unstructured":"Wolfe D, Kanji S, Yazdi F, Barbeau P, Rice D, Beck A, Butler C, Esmaeilisaraji L, Skidmore B, Moher D and Hutton B. Drug induced pancreatitis: a systematic review of case reports to determine potential drug associations. PLoS One 2020; 15: e0231883.","DOI":"10.1371\/journal.pone.0231883"},{"key":"ref27","doi-asserted-by":"publisher","first-page":"1293294","DOI":"10.3389\/fphar.2023.1293294","article-title":"Organ-specific immune-mediated reactions to polyethylene glycol and polysorbate excipients: three case reports","volume":"14","author":"Rogozina","year":"2023","unstructured":"Rogozina O, Ruiz-Fernandez C, Martin-Lopez S, Akatbach-Bousaid I, Gonzalez-Munoz M and Ramirez E. Organ-specific immune-mediated reactions to polyethylene glycol and polysorbate excipients: three case reports. Front Pharmacol 2023; 14: 1293294.","journal-title":"Front Pharmacol"},{"key":"ref28","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1016\/S0016-5085(98)70212-4","article-title":"Acute pancreatitis due to pyritinol: an immune-mediated phenomenon","volume":"115","author":"Straumann","year":"1998","unstructured":"Straumann A, Bauer M, Pichler WJ and Pirovino M. Acute pancreatitis due to pyritinol: an immune-mediated phenomenon. Gastroenterology 1998; 115: 452-454.","journal-title":"Gastroenterology"},{"key":"ref29","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/j.trsl.2022.06.007","article-title":"C-Abl tyrosine kinase inhibition attenuate oxidative stress-induced pancreatic beta-cell dysfunction via glutathione antioxidant system","volume":"249","author":"Karunakaran","year":"2022","unstructured":"Karunakaran U, Elumalai S, Moon JS and Won KC. C-Abl tyrosine kinase inhibition attenuate oxidative stress-induced pancreatic beta-cell dysfunction via glutathione antioxidant system. Transl Res 2022; 249: 74-87.","journal-title":"Transl Res"},{"key":"ref30","doi-asserted-by":"publisher","unstructured":"Radulova-Mauersberger O, Belyaev O, Birgin E, Bosch F, Brunner M, Muller-Debus CF, Wellner UF, Grutzmann R, Keck T, Werner J, Uhl W and Witzigmann H. Indications for surgical and interventional therapy of acute pancreatitis. Zentralbl Chir 2020; 145: 374-382.","DOI":"10.1055\/a-1164-7099"},{"key":"ref31","doi-asserted-by":"publisher","first-page":"614","DOI":"10.3748\/wjg.v30.i7.614","article-title":"Pathophysiology of severe gallstone pancreatitis: a new paradigm","volume":"30","author":"Isogai","year":"2024","unstructured":"Isogai M. Pathophysiology of severe gallstone pancreatitis: a new paradigm. World J Gastroenterol 2024; 30: 614-623.","journal-title":"World J Gastroenterol"},{"key":"ref32","unstructured":"Schroder H and Goring G. Reactive involvement of the pancreas in biliary tract disorders. Zentralbl Chir 1971; 96: 1614-1620."},{"key":"ref33","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1212\/WNL.0000000000002864","article-title":"Efficacy and safety of brivaracetam for partial-onset seizures in 3 pooled clinical studies","volume":"87","author":"Ben-Menachem","year":"2016","unstructured":"Ben-Menachem E, Mameniskiene R, Quarato PP, Klein P, Gamage J, Schiemann J, Johnson ME, Whitesides J, Mcdonough B and Eckhardt K. Efficacy and safety of brivaracetam for partial-onset seizures in 3 pooled clinical studies. Neurology 2016; 87: 314-323.","journal-title":"Neurology"},{"key":"ref34","doi-asserted-by":"publisher","first-page":"1027","DOI":"10.1212\/01.wnl.0000271385.85302.55","article-title":"Evaluation of brivaracetam, a novel SV2a ligand, in the photosensitivity model","volume":"69","author":"Kasteleijn-Nolst Trenit&#xE9","year":"2007","unstructured":"Kasteleijn-Nolst Trenité DG, Genton P, Parain D, Masnou P, Steinhoff BJ, Jacobs T, Pigeolet E, Stockis A and Hirsch E. Evaluation of brivaracetam, a novel SV2a ligand, in the photosensitivity model. Neurology 2007; 69: 1027-1034.","journal-title":"Neurology"},{"key":"ref35","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1007\/s40265-016-0555-6","article-title":"Brivaracetam: first global approval","volume":"76","author":"Markham","year":"2016","unstructured":"Markham A. Brivaracetam: first global approval. Drugs 2016; 76: 517-522.","journal-title":"Drugs"},{"key":"ref36","doi-asserted-by":"publisher","first-page":"643","DOI":"10.2147\/DDDT.S103468","article-title":"New developments in the management of partial-onset epilepsy: role of brivaracetam","volume":"11","author":"Coppola","year":"2017","unstructured":"Coppola G, Iapadre G, Operto FF and Verrotti A. New developments in the management of partial-onset epilepsy: role of brivaracetam. Drug Des Devel Ther 2017; 11: 643-657.","journal-title":"Drug Des Devel Ther"},{"key":"ref37","doi-asserted-by":"publisher","first-page":"792","DOI":"10.1124\/dmd.115.069161","article-title":"Effect of rifampin on the disposition of brivaracetam in human subjects: further insights into brivaracetam hydrolysis","volume":"44","author":"Stockis","year":"2016","unstructured":"Stockis A, Watanabe S, Scheen AJ, Tytgat D, Gerin B, Rosa M, Chanteux H and Nicolas JM. Effect of rifampin on the disposition of brivaracetam in human subjects: further insights into brivaracetam hydrolysis. Drug Metab Dispos 2016; 44: 792-799.","journal-title":"Drug Metab Dispos"}],"container-title":["American Journal of Translational Research"],"original-title":[],"link":[{"URL":"https:\/\/e-century.us\/files\/ajtr\/17\/10\/ajtr0165811.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,23]],"date-time":"2026-01-23T01:48:42Z","timestamp":1769132922000},"score":1,"resource":{"primary":{"URL":"https:\/\/e-century.us\/files\/ajtr\/17\/10\/ajtr0165811.pdf"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025]]},"references-count":38,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.62347\/edns9849","relation":{},"ISSN":["1943-8141"],"issn-type":[{"value":"1943-8141","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025]]}}}